Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study
Nom du journal : J Clin Oncol
Année : 2012
Volume : 30
Page de départ : 2718
Page de fin : 2724